William P. Tansey

机构：Vanderbilt University, Vanderbilt University Medical Center · ORCID：0000-0002-3900-0978

发表论文 176 篇 · 总被引 8862 次 · h-index 46

代表论文

• WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines (2023 · Oncogenesis · 被引 23)
• WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think (2024 · Journal of Clinical Medicine · 被引 20)
• Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition (2023 · eLife · 被引 18)
• Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies (2024 · Proceedings of the National Academy of Sciences · 被引 13)
• Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors (2023 · Journal of Medicinal Chemistry · 被引 10)
• Ribosome-directed cancer therapies: the tip of the iceberg? (2025 · Trends in Pharmacological Sciences · 被引 7)